ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

AACI Opposes Most Guidelines Proposals But Can’t Agree On Research Based Ceiling

May 2, 1980

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998

HHS Draft of Bill Reauthorizing NIH Specifically Kills Bypass Budget, Would End National Cancer Act of 1971

March 29, 1985